Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-012780

Chief R&D Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thackray Helen M. · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-31 Grant or award : show line 1 in the form +100,000 100,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-31 Grant or award : show line 2 in the form Emp. Stock Option (Right to Buy) +400,000 400,000 D
Loading xslF345X03/form4.xml…